(Abst.) Drug-induced liver injury associated w/biosimilar glatiramer acetate (Clift) on: January 24, 2020, 07:41:02 pm #1 From PubMed, January 24, 2020--"Drug-induced liver injury associated with the biosimilar glatiramer acetate (Clift)": Drug-induced liver injury associated with the biosimilar glatiramer acetate (Clift®) - PubMed A 23-year old female was diagnosed with relapsing-remitting multiple sclerosis with two symptomatic attacks. Immunomodulatory treatment with Clift® (Glatiramer Acetate biosimilar) was initiated. S... PubMed · ncbi.nlm.nih.gov Logged MS Speaks--online for 20 yearsSPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) 12/16/20 - 3/16/24.
